SCHEMBL19310143

SCHEMBL19310143

BC(B)(Nc1cccc2c1C(B)(B)N(C1(B)CCC(=O)NC1=O)C2=O)c1ccc(C(B)(B)N2C(B)(B)C(B)(B)OC(B)(B)C2(B)B)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23864786 0.68 CRBN (0.39) —
SCHEMBL19310114 0.68 — —
SCHEMBL21927112 0.66 — —
SCHEMBL21925688 0.63 — —
SCHEMBL21924038 0.63 — —
SCHEMBL21281328 0.57 CYP19A1 (0.35) —
SCHEMBL19451258 0.54 CRBN (0.39) —
SCHEMBL22857745 0.53 CRBN (0.38) —
SCHEMBL23979357 0.53 CRBN (0.42) —
SCHEMBL23979399 0.53 CRBN (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3214081-A1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Kangpu Biopharmaceuticals, Ltd. (CN) 2017-09-06 — — EP disclosed
Send feedback